European Union Launches Digital COVID-19 Vaccine Certificate
The European Union has announced that it will be officially launching a digital COVID-19 certificate for all E.U. citizens and residents, as well as for specific categories of travelers by July 1, 2021.1 What is the Digital COVID-19 Certificate? The E.U. Digital COVID Certificate is a mobile app that provides information such as the digital […]
COVID “Health Pass” Approved by France’s Parliament
On May 12, 2021, the French National Assembly passed a bill approving the use of a COVID pass sanitaire or “health pass.” The pass, which would be in digital form or paper, would be required as of June 9 to prove an individual has either been fully vaccinated for COVID-19, recently tested negative for SARS-CoV-2 […]
Pfizer Poised to Dominate U.S. Market for COVID-19 Biologics
Last week was a bad one for COVID-19 biologics produced by Moderna, Inc. and Johnson & Johnson, Inc. (J&J). News reports began filtering out about new research from the U.S. Centers for Disease Control and Prevention (CDC), which were published on Apr. 5, 2021 in the journal JAMA and revealed that people who receive Moderna’s […]
European Union Plans Vaccine ‘Passport’ Allowing Summer Travel
The European Commission really doesn’t want this to be called a vaccine passport. They’re calling it a digital green pass or certificate, and this would essentially be in the form of a QR code—those funny little square barcodes that we’re all getting so used to seeing around in restaurants and things to scan and find […]
AstraZeneca’s COVID-19 Vaccine Not Recommended for People Over 65 in Germany
Health officials in Germany have cautioned that the AstraZeneca/Oxford University COVID-19 vaccine (AZD1222) should not be given to people over the age of 65. Germany’s disease control agency, the Robert Koch Institute, only recommends the shot for people between the ages of 18-64 after concluding that there is not enough data available to determine whether the […]
CureVac’s COVID-19 Vaccine Produces Grade 3 Adverse Events
Biopharmaceutical company CureVac NV of Tübingen, Germany has released the interim results of its Phase 1 clinical trial on its experimental CVnCoV vaccine COVID-19. The vaccine, which was given to more than 250 healthy adults 18 to 60 years of age, is based on messenger ribonucleic acid (mRNA) technology.1 2 Unlike traditional vaccines, mRNA vaccines […]